Table 5

Cost-effectiveness results for a cohort of 1000 patients, where those undergoing PCI have stopped all anti-anginal medical therapy

TreatmentTotal costsTotal QALYsCost differenceQALY differenceICER
Placebo£410 405796.092
PCI£1 913 852813.661£1 503 44717.569£85 576*
  • *ICER calculated prior to rounding.

  • ICER, incremental cost-effectiveness ratio; PCI, percutaneous coronary intervention; QALYs, quality-adjusted life-years.